J. Nathan Davis - Concepedia

Author

J. Nathan Davis

Louisiana State University Health Sciences Center Shreveport

Also Known As

J N Davis, J Nathan Davis, J. N. Davis, J. Nathan Davis, J.N. Davis, J.Nathan Davis

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Louisiana State University Health Sciences Center Shreveport St. Jude Children's Research Hospital Mayo Clinic in Arizona Louisiana State University University of Iowa

About

J. Nathan Davis is an author at Louisiana State University Health Sciences Center Shreveport specializing in medicine, cell biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.1K
2	Cell Biology	9	9	744
3	Natural Sciences	7	7	719
4	Biochemistry	4	4	390
5	Health Sciences	1	1	28

J. Nathan Davis

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
The t(12;21) Translocation Converts AML-1B from an Activator to a Repressor of Transcription Scott W. Hiebert, Wuhua Sun, J. Nathan Davis, Molecular and Cellular Biology Lymphocyte DevelopmentT-regulatory CellImmunologyMolecular BiologyImmunotherapy	1996	278
A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity. Alex A. Adjei, Charles Erlichman, J. Nathan Davis, PubMed Chemoprevention StrategyPathologyPharmacotherapyTumor BiologyTranslational Pharmacology	2000	243
Gfi‐1 attaches to the nuclear matrix, associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA‐sensitive mechanism Laura McGhee, Josh Bryan, Liza T Elliott, Journal of Cellular Biochemistry	2003	120
Comparison of potential markers of farnesyltransferase inhibition. Alex A. Adjei, J. Nathan Davis, Charles Erlichman, PubMed Molecular PharmacologyTumor BiologyFt InhibitionChemoprevention StrategyBiochemistry	2000	119
Synergy of the protein farnesyltransferase inhibitor SCH66336 and cisplatin in human cancer cell lines. Alex A. Adjei, J. Nathan Davis, Laura M. Bruzek, PubMed Chemoprevention StrategyDrug SequencingCancer BiologyGliomaTumor Biology	2001	96
The MN1-TEL Fusion Protein, Encoded by the Translocation (12;22)(p13;q11) in Myeloid Leukemia, Is a Transcription Factor with Transforming Activity Arjan Buijs, Luc Van Rompaey, Anco Molijn, Molecular and Cellular Biology Hematological MalignancyTranscriptional RegulationTransforming ActivityTel GeneMedicine	2000	95
Modulation of nucleotide sensitivity of ATP-sensitive potassium channels by phosphatidylinositol-4-phosphate 5-kinase Show‐Ling Shyng, Alejandro M. Barbieri, Aysel Gumusboga, Proceedings of the National Academy of Sciences	2000	78
A Potential Role for Elf-1 in Terminal Transferase Gene Regulation Patricia Ernst, Kyungmin Hahm, Le A. Trinh, Molecular and Cellular Biology Lymphocyte DevelopmentGeneticsImmunologyMolecular GeneticsTranscriptional Regulation	1996	58
Phosphatidylinositol-4-phosphate 5-Kinase-1β Is Essential for Epidermal Growth Factor Receptor-mediated Endocytosis M. Alejandro Barbieri, Colin Heath, Elizabeth M. Peters, Journal of Biological Chemistry	2001	56
RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from thePSA upstream regulatory region Marcie Fowler, Erkut Borazanci, Laura McGhee, Journal of Cellular Biochemistry	2005	49

Page 1